Connection

Mark Hamann to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Mark Hamann has written about Carcinoma, Hepatocellular.
Mark Hamann
Connection Strength
0.172
Carcinoma, Hepatocellular
  1. Prenylated flavonoids with significant anti-hepatoma activity from Daphne giraldii and effects on Fibroblast Growth Factor Receptor 1 (FGFR1). Eur J Med Chem. 2023 Feb 05; 247:115006.
    View in: PubMed
    Score: 0.172
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.